Melanoma Immunotherapy: Past, Present, and Future
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
3461-3473
Author(s):
F. Saleh, W. Renno, I. Klepacek, G. Ibrahim, S. Asfar, H. Dashti, P. Romero, A. Dashti and A. Behbehani
Immunotherapy and Cancer Vaccines in the Management of Breast Cancer
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
3475-3483
Author(s):
G. Sauer, C. Kurzeder, Heilmann Heilmann, R. Kreienberg and H. Deissler
Therapeutic Vaccines for Cervical Cancer: Dendritic Cell-Based Immunotherapy
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
3485-3500
Author(s):
A. D. Santin, S. Bellone, J. J. Roman, A. Burnett, M. J. Cannon and S. Pecorelli
Ligand-Targeted Liposomes for Cancer Treatment
Journal:
Current Drug Delivery
Volume:
2
Page:
369-381
Author(s):
Puja Sapra, Pradeep Tyagi and Theresa M. Allen
Lipid-based Self-Adjuvanting Vaccines
Journal:
Current Drug Delivery
Volume:
2
Page:
383-393
Author(s):
Lorena E. Brown and David C. Jackson
Cell Cycle Regulatory Kinase Modulators: Interim Progress and Issues
Journal:
Current Topics in Medicinal Chemistry
Volume:
5
Page:
1109-1117
Author(s):
Edward A. Sausville
DNA Mismatch Repair Deficiency, Resistance to Cancer Chemotherapy and the Development of Hypersensitive Agents
Journal:
Current Topics in Medicinal Chemistry
Volume:
5
Page:
1133-1149
Author(s):
Klaus Pors and Laurence H. Patterson
PNP Anticancer Gene Therapy
Journal:
Current Topics in Medicinal Chemistry
Volume:
5
Page:
1259-1274
Author(s):
Yang Zhang, William B. Parker, Eric J. Sorscher and Steven E. Ealick
Editorial [Hot Topic: The Endothelin System: Vascular Targets for Therapy in Disease (Guest Editor: Michael R. Dashwood)]
Journal:
Current Vascular Pharmacology
Volume:
3
Page:
305-307
Author(s):
Michael R. Dashwood
Endothelin-1 and Angiogenesis in Cancer
Journal:
Current Vascular Pharmacology
Volume:
3
Page:
309-314
Author(s):
Jonathan Knowles, Marilena Loizidou and Irving Taylor